Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Deoxyhemoglobin is the form of hemoglobin in which the iron atom of each heme group is in the ferrous (Fe²⁺) state and is not bound to oxygen. It predominates in venous blood and is responsible for the dark red (bluish) color of deoxygenated blood. Hemoglobin tetramers consist of two alpha and two beta subunits, each containing a heme group able to bind oxygen reversibly[2][6][9]. In the deoxy state (the "tense" or "T" state), the molecule has a lower affinity for oxygen due to a particular quaternary conformation, stabilized by salt bridges and hydrogen bonds that are disrupted during oxygen binding[1][3]. Deoxyhemoglobin plays a central physiological role in transporting oxygen from the lungs to peripheral tissues and facilitating carbon dioxide return. It is not itself a drug target in the typical sense (receptor, enzyme, transporter), though its properties and concentration are relevant in diseases such as sickle cell anemia and hypoxic states[7][9]. Some experimental drugs, such as RSR-13, target deoxyhemoglobin allosterically to increase oxygen release, but generally, it is not considered a classic therapeutic target[5]. The term "deoxyhemoglobin" refers to a conformational state of the hemoglobin protein, not a unique gene or pharmacological receptor, so it is not a canonical therapeutic target.
Allosteric modulation of oxygen-binding affinity[5] Gas binding/displacement at heme iron
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemoglobin subunit (deoxy form) (Hb (deoxyHb)).